Lifecore Biomedical Inc (LFCR)
5.875
+0.20
(+3.43%)
USD |
NASDAQ |
Nov 01, 16:00
5.88
0.00 (0.00%)
After-Hours: 20:00
Lifecore Biomedical Revenue (Quarterly): 24.70M for Aug. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 24.70M |
| May 31, 2024 | 37.89M |
| February 29, 2024 | 35.70M |
| November 30, 2023 | 30.15M |
| August 31, 2023 | 24.52M |
| May 31, 2023 | 31.15M |
| February 28, 2023 | 26.54M |
| November 30, 2022 | 21.86M |
| August 31, 2022 | 23.72M |
| May 31, 2022 | 21.13M |
| February 28, 2022 | 37.40M |
| November 30, 2021 | 43.45M |
| August 31, 2021 | 41.63M |
| May 31, 2021 | -25.76M |
| February 28, 2021 | 44.69M |
| November 30, 2020 | 130.90M |
| August 31, 2020 | 135.64M |
| May 31, 2020 | -274.17M |
| February 29, 2020 | 152.93M |
| November 30, 2019 | 142.59M |
| August 31, 2019 | 138.71M |
| May 31, 2019 | 152.78M |
| February 28, 2019 | 155.55M |
| November 30, 2018 | 124.56M |
| August 31, 2018 | 124.67M |
| Date | Value |
|---|---|
| May 31, 2018 | 141.08M |
| February 28, 2018 | 144.91M |
| November 30, 2017 | 122.46M |
| August 31, 2017 | 115.78M |
| May 31, 2017 | 64.95M |
| February 28, 2017 | 136.57M |
| November 30, 2016 | 135.86M |
| August 31, 2016 | 132.39M |
| May 31, 2016 | 71.13M |
| February 29, 2016 | 129.99M |
| November 30, 2015 | 140.44M |
| August 31, 2015 | 135.36M |
| May 31, 2015 | 134.45M |
| February 28, 2015 | 138.53M |
| November 30, 2014 | 132.66M |
| August 31, 2014 | 133.61M |
| May 31, 2014 | 120.93M |
| February 28, 2014 | 126.38M |
| November 30, 2013 | 120.03M |
| August 31, 2013 | 109.48M |
| May 31, 2013 | 107.11M |
| February 28, 2013 | 117.87M |
| November 30, 2012 | 114.65M |
| August 31, 2012 | 102.07M |
| May 31, 2012 | 82.62M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-274.17M
Minimum
May 2020
152.93M
Maximum
Feb 2020
35.33M
Average
33.42M
Median
Revenue (Quarterly) Benchmarks
| AngioDynamics Inc | 67.49M |
| Precision Optics Corp Inc | 4.716M |
| Sage Therapeutics Inc | 11.87M |
| Outset Medical Inc | 27.39M |
| NovaBay Pharmaceuticals Inc | 2.40M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.23M |
| Total Expenses (Quarterly) | 35.81M |
| EPS Diluted (Quarterly) | -0.53 |
| Enterprise Value | 338.76M |
| Gross Profit Margin (Quarterly) | 21.81% |
| Profit Margin (Quarterly) | -65.70% |
| Earnings Yield | 0.85% |
| Normalized Earnings Yield | -15.15 |